Co-Founder, Chief Science Officer and Member of Scientific Advisory BoardWe currently do not have informatin regarding Daniel Muruve. This executive tanure with Arch Biopartners Inc is not currenlty determined.
Founder Since 2013
The company has return on total asset (ROA)
of (85.15) %
which means that it has lost $85.15 on every $100 spent on asset. This is way below average.
The company has accumulated 246.87 K in total debt. Arch Biopartners Inc has Current Ratio of 2.71 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Arch Biopartners, Inc., a biotechnology company, develops solutions and technologies for medical use. Arch Biopartners Inc (FOIFF) is traded on OTC Market in USA. It is located in Arch Biopartners, Inc.Toronto, ON MV M and employs 9 people.